{"entity":{"type":"insider","cik":"0001797819","url":"/insider/0001797819","json_url":"/insider/0001797819.json","name":"De Backer Marianne","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":24,"n_filings":13,"first":"2020-06-24","last":"2026-04-07","span_basis":"filed_date"},"name_variants":[{"name":"De Backer Marianne","source":"filing","n_filings":13,"first_seen":"2020-06-24","last_seen":"2026-04-07"}],"transactions":[{"id":5787373,"accession":"0001628280-26-024098","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-024098","line_url":"/filing/0001628280-26-024098#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (President and CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President and CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72559.0,"shares_display":"72,559","price_per_share":9.156,"price_display":"9.16","price_state":"stated","total_value":664350.204,"total_display":"664,350.20","total_whole":"664,350","shares_owned_after":948145.0,"shares_owned_after_display":"948,145","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-04-06","filed_date":"2026-04-07","scope":"insider"},{"id":5933563,"accession":"0001628280-26-012390","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-26-012390","line_url":"/filing/0001628280-26-012390#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14762.0,"shares_display":"14,762","price_per_share":9.5326,"price_display":"9.53","price_state":"stated","total_value":140720.2412,"total_display":"140,720.24","total_whole":"140,720","shares_owned_after":1020704.0,"shares_owned_after_display":"1,020,704","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-24","filed_date":"2026-02-26","scope":"insider"},{"id":5917605,"accession":"0001628280-26-011327","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-26-011327","line_url":"/filing/0001628280-26-011327#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":19039.0,"shares_display":"19,039","price_per_share":7.4528,"price_display":"7.45","price_state":"stated","total_value":141893.8592,"total_display":"141,893.86","total_whole":"141,894","shares_owned_after":1035466.0,"shares_owned_after_display":"1,035,466","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-23","filed_date":"2026-02-24","scope":"insider"},{"id":5173478,"accession":"0001628280-25-016800","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-25-016800","line_url":"/filing/0001628280-25-016800#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":79712.0,"shares_display":"79,712","price_per_share":5.9494,"price_display":"5.95","price_state":"stated","total_value":474238.5728,"total_display":"474,238.57","total_whole":"474,239","shares_owned_after":769505.0,"shares_owned_after_display":"769,505","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-04-03","filed_date":"2025-04-04","scope":"insider"},{"id":4182448,"accession":"0001628280-25-007693","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001628280-25-007693","line_url":"/filing/0001628280-25-007693#line-2","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":16122.0,"shares_display":"16,122","price_per_share":9.4534,"price_display":"9.45","price_state":"stated","total_value":152407.7148,"total_display":"152,407.71","total_whole":"152,408","shares_owned_after":849217.0,"shares_owned_after_display":"849,217","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-02-24","filed_date":"2025-02-25","scope":"insider"},{"id":3186940,"accession":"0001628280-24-014878","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001628280-24-014878","line_url":"/filing/0001628280-24-014878#line-1","is_derivative":false,"issuer_cik":"0001706431","issuer_name":"Vir Biotechnology, Inc.","issuer_ticker":"VIR","issuer_name_source":null,"issuer_url":"/issuer/0001706431","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director, Officer (Chief Executive Officer)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Executive Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":72995.0,"shares_display":"72,995","price_per_share":9.4577,"price_display":"9.46","price_state":"stated","total_value":690364.8115,"total_display":"690,364.81","total_whole":"690,365","shares_owned_after":678457.0,"shares_owned_after_display":"678,457","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-04-03","filed_date":"2024-04-04","scope":"insider"},{"id":6722015,"accession":"0001209191-22-001323","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-22-001323","line_url":"/filing/0001209191-22-001323","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4500.0,"shares_display":"4,500","price_per_share":64.70596444444445,"price_display":"64.71","price_state":"stated","total_value":291176.84,"total_display":"291,176.84","total_whole":"291,177","shares_owned_after":19256.0,"shares_owned_after_display":"19,256","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-01-03","filed_date":"2022-01-04","scope":"insider","n_lines":3},{"id":5538092,"accession":"0001209191-21-067658","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-067658","line_url":"/filing/0001209191-21-067658#line-1","is_derivative":false,"issuer_cik":"0001741830","issuer_name":"Kronos Bio, Inc.","issuer_ticker":"KRON","issuer_name_source":null,"issuer_url":"/issuer/0001741830","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1150.0,"shares_display":"1,150","price_per_share":11.57,"price_display":"11.57","price_state":"stated","total_value":13305.5,"total_display":"13,305.50","total_whole":"13,306","shares_owned_after":2750.0,"shares_owned_after_display":"2,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-12-01","filed_date":"2021-12-02","scope":"insider"},{"id":5294437,"accession":"0001209191-21-053243","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-21-053243","line_url":"/filing/0001209191-21-053243","is_derivative":false,"issuer_cik":"0001741830","issuer_name":"Kronos Bio, Inc.","issuer_ticker":"KRON","issuer_name_source":null,"issuer_url":"/issuer/0001741830","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":19.565,"price_display":"19.56","price_state":"stated","total_value":19565.0,"total_display":"19,565.00","total_whole":"19,565","shares_owned_after":1600.0,"shares_owned_after_display":"1,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-08-20","filed_date":"2021-08-24","scope":"insider","n_lines":2},{"id":5200240,"accession":"0001209191-21-043406","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-043406","line_url":"/filing/0001209191-21-043406#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5000.0,"shares_display":"5,000","price_per_share":89.85,"price_display":"89.85","price_state":"stated","total_value":449250.0,"total_display":"449,250.00","total_whole":"449,250","shares_owned_after":21500.0,"shares_owned_after_display":"21,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-06-24","filed_date":"2021-06-25","scope":"insider"},{"id":5333682,"accession":"0001209191-21-036799","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-036799","line_url":"/filing/0001209191-21-036799#line-1","is_derivative":false,"issuer_cik":"0001741830","issuer_name":"Kronos Bio, Inc.","issuer_ticker":"KRON","issuer_name_source":null,"issuer_url":"/issuer/0001741830","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":600.0,"shares_display":"600","price_per_share":25.01,"price_display":"25.01","price_state":"stated","total_value":15006.0,"total_display":"15,006.00","total_whole":"15,006","shares_owned_after":600.0,"shares_owned_after_display":"600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-28","filed_date":"2021-06-01","scope":"insider"},{"id":2473195,"accession":"0001209191-20-055851","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-055851","line_url":"/filing/0001209191-20-055851","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":50.465,"price_display":"50.46","price_state":"stated","total_value":50465.0,"total_display":"50,465.00","total_whole":"50,465","shares_owned_after":17000.0,"shares_owned_after_display":"17,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-08","filed_date":"2020-10-26","scope":"insider","n_lines":2},{"id":2586117,"accession":"0001209191-20-038767","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-8","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":31.33,"price_display":"31.33","price_state":"stated","total_value":15665.0,"total_display":"15,665.00","total_whole":"15,665","shares_owned_after":16500.0,"shares_owned_after_display":"16,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-06-15","filed_date":"2020-06-24","scope":"insider"},{"id":2586111,"accession":"0001209191-20-038767","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-7","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":35.4,"price_display":"35.40","price_state":"stated","total_value":17700.0,"total_display":"17,700.00","total_whole":"17,700","shares_owned_after":16000.0,"shares_owned_after_display":"16,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-04-15","filed_date":"2020-06-24","scope":"insider"},{"id":2586108,"accession":"0001209191-20-038767","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-6","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":23.94,"price_display":"23.94","price_state":"stated","total_value":11970.0,"total_display":"11,970.00","total_whole":"11,970","shares_owned_after":15500.0,"shares_owned_after_display":"15,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-16","filed_date":"2020-06-24","scope":"insider"},{"id":2586042,"accession":"0001209191-20-038767","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-5","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":24.8,"price_display":"24.80","price_state":"stated","total_value":12400.0,"total_display":"12,400.00","total_whole":"12,400","shares_owned_after":15000.0,"shares_owned_after_display":"15,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-12","filed_date":"2020-06-24","scope":"insider"},{"id":2586038,"accession":"0001209191-20-038767","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-4","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":28.6,"price_display":"28.60","price_state":"stated","total_value":14300.0,"total_display":"14,300.00","total_whole":"14,300","shares_owned_after":14500.0,"shares_owned_after_display":"14,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-03-11","filed_date":"2020-06-24","scope":"insider"},{"id":2586034,"accession":"0001209191-20-038767","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-3","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":34.39,"price_display":"34.39","price_state":"stated","total_value":17195.0,"total_display":"17,195.00","total_whole":"17,195","shares_owned_after":14000.0,"shares_owned_after_display":"14,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-28","filed_date":"2020-06-24","scope":"insider"},{"id":2586030,"accession":"0001209191-20-038767","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-2","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":35.07,"price_display":"35.07","price_state":"stated","total_value":17535.0,"total_display":"17,535.00","total_whole":"17,535","shares_owned_after":13500.0,"shares_owned_after_display":"13,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-02-27","filed_date":"2020-06-24","scope":"insider"},{"id":2586021,"accession":"0001209191-20-038767","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-038767","line_url":"/filing/0001209191-20-038767#line-1","is_derivative":false,"issuer_cik":"0000879407","issuer_name":"ARROWHEAD PHARMACEUTICALS, INC.","issuer_ticker":"ARWR","issuer_name_source":null,"issuer_url":"/issuer/0000879407","owner_cik":"0001797819","owner_name":"De Backer Marianne","owner_display_name":"De Backer Marianne","owner_url":"/insider/0001797819","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":500.0,"shares_display":"500","price_per_share":54.95,"price_display":"54.95","price_state":"stated","total_value":27475.0,"total_display":"27,475.00","total_whole":"27,475","shares_owned_after":13000.0,"shares_owned_after_display":"13,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-01-13","filed_date":"2020-06-24","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":24,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":14,"open_market":true},{"code":"S","label":"Open-market sale","n":10,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":24},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001706431","name":"Vir Biotechnology, Inc.","url":"/issuer/0001706431","role":"Director, Officer (President and CEO)","n_filings":6,"first_seen":"2024-04-04","last_seen":"2026-04-07"},{"type":"issuer","type_label":"ISSUER","cik":"0000879407","name":"ARROWHEAD PHARMACEUTICALS, INC.","url":"/issuer/0000879407","role":"Director","n_filings":4,"first_seen":"2020-06-24","last_seen":"2022-01-04"},{"type":"issuer","type_label":"ISSUER","cik":"0001741830","name":"Kronos Bio, Inc.","url":"/issuer/0001741830","role":"Director","n_filings":3,"first_seen":"2021-06-01","last_seen":"2021-12-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001797819","retrieved_at":"2026-08-27T01:11:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}